1)川上憲人:精神疾患の有病率等に関する大規模疫学調査研究.世界精神保健日本調査セカンド,2016
2)Bruce SE, Yonkers KA, Otto MW, et al:Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder:a 12-year prospective study. Am J Psychiatry 162:1179-1187, 2005
3)Bandelow B, Lichte T, Rudolf S, et al:The diagnosis of and treatment recommendations for anxiety disorders. Dtsch Arztebl Int 111:473-480, 2014
4)American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, 5th ed(DSM-5). American Psychiatric Publishing, Washington DC, 2013[日本精神神経学会(日本語版用語監修),髙橋三郎,大野裕(監訳):DSM-5精神疾患の診断・統計マニュアル.医学書院,2014]
5)日本不安症学会,日本神経精神薬理学会(編):社交不安症診療ガイドライン.日本医療機能評価機構Mindsガイドラインライブラリー,2021
6)Goldstein-Piekarski AN, Williams LM, Humphreys K:A trans-diagnostic review of anxiety disorder comorbidity and the impact of multiple exclusion criteria on studying clinical outcomes in anxiety disorders. Transl Psychiatry 6:e847, 2016
7)Angst J, Vollrath M:The natural history of anxiety disorders. Acta Psychiatr Scand 84:446-452, 1991
8)Brooks SJ, Stein DJ:A systematic review of the neural bases of psychotherapy for anxiety and related disorders. Dialogues Clin Neurosci 17:261-279, 2015
9)Li X, Inoue T, Abekawa T, et al:5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala. Eur J Pharmacol 532:74-80, 2006
10)Stein MB, Stein DJ:Social anxiety disorder. Lancet 371:1115-1125, 2008
11)Koen N, Stein DJ:Pharmacotherapy of anxiety disorders:a critical review. Dialogues Clin Neurosci 13:423-437, 2011
12)Donovan MR, Glue P, Kolluri S, et al:Comparative efficacy of antidepressants in preventing relapse in anxiety disorders-a meta-analysis. J Affect Disord 123:9-16, 2010
13)van Dis EAM, van Veen SC, Hagenaars MA, et al:Long-term outcomes of cognitive behavioral therapy for anxiety-related disorders:a systematic review and meta-analysis. JAMA Psychiatry 77:265-273, 2020
14)Lorimer B, Kellett S, Nye A, et al:Predictors of relapse and recurrence following cognitive behavioural therapy for anxiety-related disorders:a systematic review. Cogn Behav Ther 50:1-18, 2021
15)松田泰範,井上幸紀:パニック症/パニック障害の残遺症状.精神科治療学 30:747-751, 2015
16)大坪天平:全般不安症/全般性不安障害の残遺症状とそれへの対策.精神科治療学 30:753-760, 2015
17)Swoboda H, Amering M, Windhaber J, et al:The long-term course of panic disorder--an 11 year follow-up. J Anxiety Disord 17:223-232, 2003
18)Andersch S, Hetta J:A 15-year follow-up study of patients with panic disorder. Eur Psychiatry 18:401-408, 2003
19)Yonkers KA, Dyck IR, Warshaw M, et al:Factors predicting the clinical course of generalised anxiety disorder. Br J Psychiatry 176:544-549, 2000
20)Keller MB:The long-term clinical course of generalized anxiety disorder. J Clin Psychiatry 63:11-16, 2002
21)Steinert C, Hofmann M, Leichsenring F, et al:What do we know today about the prospective long-term course of social anxiety disorder? A systematic literature review. J Anxiety Disord 27:692-702, 2013
22)Hung CI, Liu CY, Yang CH, et al:Comorbidity with more anxiety disorders associated with a poorer prognosis persisting at the 10-year follow-up among patients with major depressive disorder. J Affect Disord 260:97-104, 2020
23)Gibby BA, Casline EP, Ginsburg GS:Long-term outcomes of youth treated for an anxiety disorder:a critical review. Clin Child Fam Psychol Rev 20:201-225, 2017
24)Stott J, Saunders R, Desai R, et al:Associations between psychological intervention for anxiety disorders and risk of dementia:a prospective cohort study using national health-care records data in England. Lancet Healthy Longev 4:e12-e22, 2023
25)山下格:対人恐怖.金原出版,1977